Skip to Main Content

Try STAT+ TODAY

politics

Most Read

Trump medication

The Pharmalot View By Ed Silverman

Oh, the irony! Trump may like to vilify drug makers, but now he needs them more than ever

NIH Brain - Murthy

Politics By Lev Facher

Q&A: Vivek Murthy, a top Biden adviser, on Covid-19 vaccines, the drug industry, and the future of public health

Barbara Bollier

Politics By Lev Facher

A Senate race in Kansas between two doctors sets the stage for an election hyper-focused on health policy — and on Covid-19

Special Report By Lev Facher

Pharma is showering Congress with cash, even as drug makers race to fight the coronavirus

Donald Trump 3/16

Politics By Lev Facher

Trump urges people to avoid discretionary travel and limit gatherings to fewer than 10 people

MAINE VACCINE REFERENDUM

Politics By Lev Facher

‘Reject Big Pharma’: Anti-vaccine activists co-opt a populist slogan to try to repeal a state immunization law

Trump Pence coronavirus briefing

Politics By Lev Facher

Trump taps Pence to lead U.S. coronavirus response

Off the Charts

Off the Charts By Jennifer Adaeze Okwerekwu

As medical professionals, my husband and I know the Nigerian travel ban is cruel. Now the pain is personal

All Coverage

money pile

Pharmalot By Ed Silverman

Some drug makers quietly resumed donations to lawmakers who denied Biden’s election victory

Kelvin Droegemeier

Exclusive By Nicholas Florko

Abandoned Trump order on the bioeconomy highlights a path forward for Biden — but with mixed reviews

advertisement

Millions of dollars

Pharmalot By Ed Silverman

Pfizer shareholders are urged to reject political spending that contradicts ‘company values’

Deborah Birx coronavirus task force

Health By Kate Sheridan

‘I’m not looking to be vindicated,’ Deborah Birx says in televised interview

bernie biden debate

Politics By Lev Facher

Elbow bumps, social distancing, and Medicare for All: The coronavirus pandemic dominated every aspect of the Democratic debate

Pete Buttigieg

Politics By Andrew Joseph

In their words: Warren, Buttigieg, Klobuchar, and other Democrats explain exactly how they’d lower drug prices

Wide shot insulin protest Cambridge

Politics By Nicholas Florko

More than a dozen Democrats are bringing people with sky-high insulin bills to the State of the Union

Rep. Greg Walden

Politics By Lev Facher

House Republicans fuel Capitol Hill chaos with competing drug pricing bill

Pharmalot By Ed Silverman

Pharmalittle: Purdue bankruptcy sets tone for opioid cases; Sanders criticizes Biden for praising pharma

SPRAVATO

Politics By Lev Facher and Ed Silverman

VA declines broad coverage for new J&J depression drug touted by Trump

Pharma By Priyanka Dayal McCluskey — Boston Globe

WHO rescinds opioid guidelines following criticism by two U.S. lawmakers

White House evening

Politics By Megan Thielking

A new push aims to bring mental health and addiction into the 2020 campaign conversation

Dan Crenshaw

Politics By Lev Facher

These Republicans campaigned on a bold drug-pricing pledge. Since they won, they’ve gone silent

Fenway Park

Politics By Nicholas Florko

How do you improve Medicare? Maybe you watch Major League Baseball

Gottlieb vote

The Pharmalot View By Ed Silverman

Tweet this: Gottlieb’s leaving, and so is FDA’s highly effective communicator

D.C. Insight IMAGE

Politics By Lev Facher and Nicholas Florko

Webinar: Is the new Congress ready to lower drug costs?

Pharma CEO photo illustration

Politics By Rick Berke

A letter from Executive Editor Rick Berke: All eyes on today’s drug pricing hearing

Pharmacy shelves

Politics By Nicholas Florko

Defending the middlemen: JC Scott on testifying before Congress, challenging Trump, and revamping PBMs’ image

Sean Parker

Heavyweights By Rick Berke

Billionaire Sean Parker calls China’s gene-edited babies ‘Sputnik 2.0,’ praises FDA, and offers career advice for millennials

Alexandria Ocasio-Cortez

Biotech By Damian Garde, Rebecca Robbins and Adam Feuerstein

A tweet from Alexandria Ocasio-Cortez prompts a deeper debate over how drugs are made

Bernie Sanders

Pharmalot By Ed Silverman

Sanders accuses a drug maker of ‘immoral exploitation’ for the price of a rare disease drug

Marylou Sudders

Pharmalot By Ed Silverman

Here’s how Massachusetts officials hope to lower their Medicaid drug spending

Clarence Hogan

Politics By Robert Weisman — Boston Globe

Drug costs plague seniors, but legislative relief may be elusive

3 to Watch: Legislative Battles

Politics By Lev Facher

3 state legislative battles to watch in 2019

Taxes Health Care Q&A

Pharmalot By Ed Silverman

Big drug makers are socking away more cash lately thanks to the tax overhaul, and it’s likely to be used for more deals